World shares mostly gain as South Korea’s Kospi jumps 3.6%
HONG KONG (AP) — World shares mostly gained and U.S. futures advanced on Tuesday, with markets trading higher…
America In Focus: US inflation cooled in June, but AI build-out poses latest threat
The economy, inflation and how those forces could impact the lives of Americans were front and center over…
Massive AI buildout poses latest inflation threat as consumers pay more for laptops and electricity
WASHINGTON — American consumers — and the Federal Reserve — are being hit with another high-cost headache .…
Why Micron Technology (MU) Is Securing Long-Term AI Memory Demand With $22 Billion in Customer Commitments
Micron Technology, Inc. (NASDAQ:MU) is one of the best performing AI stocks over the last 3 years, with…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Canada eyes eastern expansion with proposed western oil pipeline
TORONTO (AP) — Alberta and Ontario proposed a pipeline Monday to carry western Canadian oil east, seeking to…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Most U.S. stocks climb toward the finish of a strong week, but drops for tech keep indexes mixed
NEW YORK (AP) — Most U.S. stocks are rising Thursday after the latest update on the job market…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Unicycive Therapeutics Receives Complete Response Letter
— Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor — — FDA inspection of…
Key inflation gauge surges to 3-year high, mortgage rates up
The economy, inflation and how those forces could impact the lives of Americans were front and center over…